Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling - Wikidata - awgldk - TriplyDB

Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling

Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling

http://www.wikidata.org/entity/Q36919811

about

Ceramide Synthase 6 Is a Novel Target of Methotrexate Mediating Its Antiproliferative Effect in a p53-Dependent Manner Autophagy and cancer therapy.Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells.PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects Differential regulation of autophagy and cell viability by ceramide species.The afatinib resistance of in vivo generated H1975 lung cancer cell clones is mediated by SRC/ERBB3/c-KIT/c-MET compensatory survival signaling.Phase I study of pemetrexed with sorafenib in advanced solid tumors.HDAC inhibitors enhance the lethality of low dose salinomycin in parental and stem-like GBM cells Src mediates extracellular signal-regulated kinase 1/2 activation and autophagic cell death induced by cardiac glycosides in human non-small cell lung cancer cell lines.[Pemetrexed + Sorafenib] lethality is increased by inhibition of ERBB1/2/3-PI3K-NFκB compensatory survival signaling.In vitro genotoxicity and cytotoxicity of a particular combination of pemetrexed and cefixime in human peripheral blood lymphocytes.ERK plays the baddie (again).Ceramide in the prostate.PP2A as the Main Node of Therapeutic Strategies and Resistance Reversal in Triple-Negative Breast Cancer.

P2860

Q28552611-BB3AF305-7155-4910-9FEB-36B70FD52D9B Q33584607-1D528030-7471-4B39-8E4F-9EA40C338F6C Q34276149-3A079301-B00A-48C4-8A46-2F2B75F9F5A4 Q35552005-36E96D8C-7EB2-4DE8-B600-7C3C2BEF03F9 Q36214943-A3A00250-CFDC-493B-A9FE-B5554DD99D79 Q37190128-E2FA66A9-A15F-4230-A846-19AF75E9280B Q37520649-3812F899-E1BC-4F16-B44F-45D60218B4B5 Q37683049-7B3BF43D-569E-4237-8B20-091FA3E478FD Q39017201-34A60656-58EF-4EAD-8AED-1E55A6E793F5 Q39888747-4BD9C29B-EE46-4D0E-8941-5508993DE130 Q41929082-ACF316B8-87CE-46DB-AA86-DB9E3854A0FC Q41958095-A50FD5EF-6B5E-4884-B6F4-0EE318CA7663 Q41960726-86CF0FC8-1631-42BD-820D-CEA3DCDD84F9 Q47271622-E32FCB8E-D4EA-4BE1-8323-123996F270BD

P2860

Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling

http://www.wikidata.org/entity/Q36919811

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling

@en

type

label

Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling

@en

prefLabel

Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling

@en

P1433

Q36919811-31DF03BD-3363-4ACD-8157-02886DFEF3DD

P1476

Q36919811-B5EEF718-86B3-46A5-9CC9-03928A6C07B6

P2093

Q36919811-32D766A8-2B39-4D19-9859-EE898D2CC2B5

Q36919811-84B21A6F-3119-4B7A-974C-07BFAFCCCF29

Q36919811-B1F79E4E-2F02-49F6-BB8D-0C0265671985

Q36919811-BCAB744A-F2BB-4515-9ECA-6A890CF42FF0

Q36919811-C6D85953-67C8-4059-A9A2-A9ECCE9C5243

Q36919811-D54D350E-ECD2-4BF0-AB2B-974DC6D96BCF

Q36919811-D5C270A8-CAE6-4ADA-881E-866734FE972D

Q36919811-F99D71A1-0316-4C15-88A8-5B90B5581F64

P2860

Q36919811-143904C6-8F87-471E-8E25-A78CE1551F42

Q36919811-151761C9-41EE-4518-BCE0-337DDDB96403

Q36919811-172AA2AB-1B35-41B1-B6C4-D4F3656D89BD

Q36919811-1A00E397-3AD7-47BA-B70F-90710C24DB31

Q36919811-20037A37-95B4-4D43-9993-BE1A32006154

Q36919811-23959FAC-B4A3-4535-A4BD-8641AD5F8B06

Q36919811-23AA2BC9-BB7F-463F-B403-42BC25395D57

Q36919811-24F281B4-08E6-43FA-A2B3-6D4180329732

Q36919811-27817339-5C8A-481F-B6F8-2AACF4473F7C

Q36919811-2A781B98-69D8-4FBB-B481-DA94F831BE87

P304

Q36919811-72D50903-F2BB-4BF5-BB89-D29DD50BB72D

P31

Q36919811-5A37D3D5-E7E6-4EA5-9C7D-04F5BA28DF4A

P356

Q36919811-8617FCAD-CF38-4F9A-952F-6CCE3E82C1F6

P433

Q36919811-C11C602B-78AF-46CA-BB92-580FD5581865

P478

Q36919811-58B2CCD9-228C-418E-BD70-F5FCDDF2B71E

P50

Q36919811-D33333CF-C904-4D5C-AD50-23605D63443B

Q36919811-F601F02C-D761-407C-BC1C-E193C09FC05D

P577

Q36919811-15B9250B-517C-4FF4-A863-B2EA74F33C59

P5875

Q36919811-43607081-45E5-4F7B-9D8A-BA7304848581

P698

Q36919811-FA113893-9DB0-4A24-89AB-C55BF9A0BB78

P932

Q36919811-57AB0DA1-1D41-477D-9004-E21A37E545D9

P356

P1433

Cancer Biology and Therapy

P1476

Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling

@en

P2093

Andrew Poklepovic

http://www.w3.org/2001/XMLSchema#string

Besim Ogretmen

http://www.w3.org/2001/XMLSchema#string

Hossein A Hamed

http://www.w3.org/2001/XMLSchema#string

Jeremy Allegood

http://www.w3.org/2001/XMLSchema#string

M Danielle Bareford

http://www.w3.org/2001/XMLSchema#string

Margaret A Park

http://www.w3.org/2001/XMLSchema#string

Nichola Cruickshanks

http://www.w3.org/2001/XMLSchema#string

Steven Grant

http://www.w3.org/2001/XMLSchema#string

P2860

Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling

Receptor tyrosine kinase signalling as a target for cancer intervention strategies

The structural requirements for ceramide activation of serine-threonine protein phosphatases

Autophagy and signaling: their role in cell survival and cell death

The roles of Bid

Mechanisms of cancer drug resistance

Recent progress of Src SH2 and SH3 inhibitors as anticancer agents.

Src family kinases, key regulators of signal transduction.

PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cells.

Sorafenib activates CD95 and promotes autophagy and cell death via Src family kinases in gastrointestinal tumor cells.

P304

793-803

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CBT.20562

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225278917

http://www.w3.org/2001/XMLSchema#string

P698

22673740

http://www.w3.org/2001/XMLSchema#string

P932

3679099

http://www.w3.org/2001/XMLSchema#string